NetEase, Inc. · NTES · FY2025 Q2 · Calendar Q3 2025
NetEase Q2 2025: Game launches drove stronger growth
The quarter supports a constructive but execution-dependent view: stronger game growth, successful launches and a broad pipeline provide evidence for continued expansion, while monetization durability and competition remain central tests.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about NTES FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current analysis describes faster overall growth and stronger gaming growth, with revenue up 9.4% year over year and gaming and value-added services up 14%. The emphasis also shifted toward monetization from Where Winds Meet and a pipeline led by Sea of Remnants, Blood Message and ANANTA.
Guidance delta
No guidance was provided in the supplied analysis.
Key takeaways
- Total revenue grew 9.4% year over year, while gaming and value-added services grew 14%.
- Where Winds Meet, Marvel-related titles and FragPunk were highlighted as monetization drivers.
- The pipeline includes Sea of Remnants, Blood Message and ANANTA, while Youdao expanded AI-enabled services.
- The balance sheet remained strong, with continued share repurchases noted in the analysis.
Management priorities
- Launch and monetize new global game titles
- Continue global publishing and content updates
- Advance AI-enabled Youdao products and advertising services
- Expand music partnerships and the upcoming game pipeline
Follow NTES with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 28, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Feb 12, 2026 |
| Benchmark | Buy | Buy | Maintain | Nov 21, 2025 |
| JP Morgan | Overweight | Neutral | Upgrade | Oct 10, 2025 |
| Arete | Buy | Sell | Upgrade | Sep 3, 2025 |
| B of A Securities | Buy | Buy | Maintain | Jan 15, 2025 |
| Citigroup | Buy | Buy | Maintain | Nov 15, 2024 |
| Jefferies | Buy | Buy | Maintain | Aug 22, 2024 |
| HSBC | Buy | Buy | Maintain | Apr 24, 2024 |
| Bernstein | Outperform | Outperform | Maintain | Jun 5, 2023 |
| UBS | Buy | Buy | Maintain | May 26, 2023 |
| 86 Research | Buy | Hold | Upgrade | Feb 25, 2022 |
| Macquarie | Neutral | Neutral | Maintain | May 19, 2021 |
| CLSA | Buy | Buy | Maintain | May 19, 2021 |
| Daiwa Capital | Buy | Buy | Maintain | Aug 14, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | May 21, 2020 |
| Nomura | Buy | Buy | Maintain | May 21, 2020 |
| CFRA | Buy | Buy | Maintain | May 20, 2020 |
| Goldman Sachs | Buy | Neutral | Upgrade | Dec 4, 2019 |
| Citi | Buy | Buy | Maintain | Sep 6, 2019 |
| Bank of America | Buy | Buy | Maintain | Nov 17, 2017 |
| Standpoint Research | Reduce | Buy | Downgrade | Jun 7, 2017 |
| Brean Capital | Buy | Buy | Maintain | Jul 18, 2016 |
| CICC | Buy | Hold | Upgrade | Apr 8, 2015 |
| Credit Suisse | Outperform | Neutral | Upgrade | Oct 21, 2014 |
| China International Capital | Hold | Buy | Downgrade | Aug 12, 2014 |
| TH Capital | Hold | Buy | Downgrade | Feb 10, 2014 |
| Deutsche Bank | Hold | Buy | Downgrade | Nov 15, 2013 |
| Exane BNP Paribas | Buy | Buy | Maintain | Sep 30, 2013 |
| PiperJaffray | Overweight | Overweight | Maintain | Aug 16, 2012 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 16, 2012 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 16, 2012 |
| Mirae Asset | Buy | Buy | Maintain | Jul 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $124.24. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Yang Liu | $163 | $115.41 | +31.2% | Sep 28, 2026 |
| BNP Paribas | Analyst unavailable | $180 | $117.47 | +44.9% | Sep 22, 2026 |
| Bernstein | Robin Zhu | $160 | $127.38 | +28.8% | Aug 21, 2026 |
| Goldman Sachs | Analyst unavailable | $169 | $129.7 | +36.0% | Jul 1, 2026 |
| Morgan Stanley | Yang Liu | $158 | $123.86 | +27.2% | May 26, 2026 |
| Morgan Stanley | Yang Liu | $154 | $114.62 | +24.0% | Mar 2, 2026 |
| Macquarie | Analyst unavailable | $158 | $118.14 | +27.2% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $132 | $118.46 | +6.2% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $135 | $133.95 | +8.7% | Nov 21, 2025 |
| Bernstein | Analyst unavailable | $155 | $133.95 | +24.8% | Nov 21, 2025 |
| Morgan Stanley | Analyst unavailable | $170 | $149.59 | +36.8% | Oct 8, 2025 |
| Goldman Sachs | Lincoln Kong | $161 | $154.83 | +29.6% | Sep 15, 2025 |
| Arete Research | Zixiao Yang | $150 | $135.71 | +20.7% | Sep 2, 2025 |
| Barclays | Jiong Shao | $120 | $129.22 | -3.4% | Aug 18, 2025 |
| Bernstein | Robin Zhu | $105 | $101.36 | -15.5% | Dec 9, 2024 |
| Barclays | Jiong Shao | $82 | $82.08 | -34.0% | Aug 26, 2024 |
| Jefferies | Thomas Chong | $103 | $82.25 | -17.1% | Aug 22, 2024 |
| Jefferies | Thomas Chong | $216 | $88 | +73.9% | Aug 5, 2024 |
| Barclays | Jiong Shao | $104 | $92.92 | -16.3% | Jun 13, 2024 |
| CFRA | Ahmad Halim | $130 | $94.74 | +4.6% | May 24, 2024 |
| Jefferies | Thomas Chong | $129 | $94.74 | +3.8% | May 23, 2024 |
| Morgan Stanley | Alex Poon | $120 | $97.15 | -3.4% | Apr 12, 2024 |
| Jefferies | Thomas Chong | $133 | $98.71 | +7.1% | Apr 2, 2024 |
| Morgan Stanley | Alex Poon | $135 | $98.71 | +8.7% | Apr 2, 2024 |
| Bernstein | Robin Zhu | $120 | $86.85 | -3.4% | Jun 5, 2023 |
| Citigroup | Analyst unavailable | $140 | $86.11 | +12.7% | Aug 19, 2022 |
| Macquarie | Esme Pau | $129 | $89.78 | +3.8% | Jul 13, 2022 |
| HSBC | Analyst unavailable | $122 | $97.49 | -1.8% | May 25, 2022 |
| CMB International Securities | Sophie Huang | $123 | $82.63 | -1.0% | Oct 5, 2021 |
| UOB Kay Hian | Julia Pan | $110 | $117.68 | -11.5% | May 20, 2021 |
| Macquarie | Han Joon Kim | $118 | $108.97 | -5.0% | May 19, 2021 |
Track every rating change on NTES the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationNetEase, Inc., a prominent technology firm founded in 1997 and headquartered in Hangzhou, People's Republic of China, delivers a broad spectrum of online services both within China and across international markets. Its core operations encompass online gaming, music streaming, intelligent online learning solutions, and diverse internet content services. The company organizes its activities into several key divisions: Games and Related Value-Added Services; Youdao, focusing on educational technology; Cloud Music for its audio streaming offerings; and a segment for Innovative Businesses and Others. Within its gaming division, NetEase is responsible for creating and managing both PC and mobile games, and it also publishes titles licensed from external game developers. The Youdao segment provides a comprehensive suite of online learning and translation tools, including Youdao Dictionary, Youdao Translation, U-Dictionary, and Youdao Kids' Dictionary.…
Historical context
All NTES earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ACN Accenture plc | FY2026 Q4 · Calendar Q4 2026 | +3.5% | +15.8% | Accenture: AI demand supports strong Q4, while pricing and geopolitics remain risks |
| JBL Jabil Inc. | FY2026 Q4 · Calendar Q3 2026 | +8.1% | -10.0% | Jabil enters FY2027 with AI-led growth and capacity risks |
| MU Micron Technology, Inc. | FY2026 Q4 · Calendar Q3 2026 | +5.4% | +0.0% | Micron: Strong AI Memory Demand, Higher Capex, and HBM4E Ahead |
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the NTES recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-11T09:40:43.789343+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-11T09:40:43.786554+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-11. For educational purposes only; not investment advice.